secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0000950170-25-041254
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus appoints Ian Hodgson as COO effective March 15, 2025
-----------------------------------------------------------

- Ian Hodgson, 52, previously Head of Operations, named COO effective March 15, 2025.
- Annual base salary of £327,869; eligible for annual bonus up to 40% of base salary.
- Employment subject to 3-month notice period; non-compete for 3 months, non-solicit for 6 months post-termination.
- Dr. Hodgson holds a PhD in Medical Microbiology, over 25 years experience in drug development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017025041254/0000950170-25-041254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017025041254/crbp-20250313.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-041254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer